# Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
Canonical URL: https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-2025-annual-meeting-date
Ticker: EGRX
Company: Eagle Pharmaceuticals
Source: Eagle Pharmaceuticals
Published: 2025-08-18 20:30 EST
Original Source URL: https://investor.eagleus.com
## Summary

WOODCLIFF LAKE, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) will be held on October 17, 2025. The specific time and place for the 2025 Annual

## Article Body
WOODCLIFF LAKE, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) will be held on October 17, 2025. The specific time and place for the 2025 Annual
## Recent Company News
- 2026-01-14 15:21 EST — [Eagle Pharmaceuticals Announces Divestiture of Barhemsys](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-divestiture-of-barhemsys) — Source: Eagle Pharmaceuticals
- 2025-10-30 10:50 EST — [Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-board-extends-limited-duration-stockholder-rights-plan) — Source: Eagle Pharmaceuticals
- 2025-10-21 20:05 EST — [Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-results-of-2025-annual-meeting-of-stockholders) — Source: Eagle Pharmaceuticals
- 2025-10-15 20:30 EST — [Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-availability-of-unaudited-second-quarter-2025-financial-statements) — Source: Eagle Pharmaceuticals
- 2025-10-06 23:30 EST — [Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-availability-of-unaudited-first-quarter-2025-financial-statements) — Source: Eagle Pharmaceuticals
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)